Trial Profile
A Double-Blind, Randomized, Parallel Group Comparison of the Effects of FX006 and TCA IR (Triamcinolone Acetonide Suspension) on Blood Glucose in Patients With Osteoarthritis of the Knee and Type 2 Diabetes Mellitus
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Jan 2024
Price :
$35
*
At a glance
- Drugs Triamcinolone (Primary) ; Triamcinolone
- Indications Osteoarthritis
- Focus Pharmacodynamics
- Sponsors Flexion Therapeutics
- 15 Nov 2023 Results of a post-hoc analysis assessing clinical meaningfulness and relevance of the results presented at the ACR Convergence 2023
- 10 Sep 2018 Results presented in a Flexion Therapeutics Media Release.
- 06 Sep 2018 Results published in the Rheumatology